Skip to Content

Alosetron use while Breastfeeding

Drugs containing Alosetron: Lotronex

Medically reviewed by Drugs.com. Last updated on July 29, 2020.

Alosetron Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of alosetron during breastfeeding. Because of relatively high protein binding and only moderate bioavailability, exposure of the breastfed infant is likely to be low. Until more data are available, alosetron should only be used with careful infant monitoring during breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Alosetron

CAS Registry Number

122852-42-0

Drug Class

  • Breast Feeding
  • Lactation
  • Gastrointestinal Agents
  • Serotonin Antagonists

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.